Biopool Gets OK to Market Clotting Reagent
Biopool International has received Food and Drug Administration approval to market a clotting reagent used to detect abnormal or low levels of a protein essential to the formation of a blood clot.
The Venom-Time Reagent represents the latest of Ventura-based Biopool’s products used for the detection and diagnosis of blood-clotting disorders.
At the request of a manufacturing client, Ortho Diagnostic Systems, Biopool successfully modified essential raw materials inherent in snake venom for the development of this reagent.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
